Ventria will present ExpressTec at the Kansas Pavilion in the Exhibit Hall and will participate in BIO’s One-on-One Partnering Sessions.
June 23, 2011 – Ventria announced that Company representatives will attend the Annual BIO Convention in Washington DC, June 27th-30th, 2011. This is the largest international event for the biotechnology industry with over 15,000 attendees from 60 countries.
Ventria will be exhibiting as part of the Kansas Pavilion at booth number 4637 and will be participating in BIO’s One-on-One partnering sessions.
“Ventria is excited to be joining the biotech industry in Washington, DC. The innovative spirit of the biotech industry thrives when we collaborate and create win-win relationships that deliver better healthcare outcomes for patients around the world,” said Scott Deeter, President and CEO, Ventria Bioscience.
###
ExpressTec is a plant-based manufacturing technology that enables safe, affordable, and sustainable production of biologics.
June 2, 2011 – Ventria Bioscience will showcase its ExpressTecTM biomanufacturing technology at the 4th International Plant-Based Vaccines & Antibodies (PBVA) Conference. Scott Deeter, President and CEO, will present “High Yielding and Scalable Plant-based Recombinant Protein Production in Monocots,” as part of the Facilities and Production plenary session on Friday, June 10th, 2011. The PBVA conference provides an international forum for the medical, veterinary, and plant biotechnology research communities to discuss the current state-of-the art in plant-based biologics technology and research and development related to new product development.
At the conference, Ventria Bioscience will discuss its experience scaling up a plant-based cGMP manufacturing system to commercial scale exceeding 1,000 kilograms of recombinant protein. To accomplish this scale, Ventria employs its proprietary recombinant protein manufacturing technology called ExpressTecTM. ExpressTecTM provides a safe, affordable, and sustainable manufacturing platform that produces target protein yields more than ten times higher than alternative systems.
“Ventria is the first company to commercialize recombinant proteins derived from a plant-based manufacturing system and has proven this technology at large scale,” said Scott Deeter, President and CEO for Ventria Bioscience. “ExpressTecTM achieves protein yields, cost-effectiveness and safety advantages that are the foundation of a portfolio of products that were previously not available to a global customer base.”
###
Lactoferrin expansion required to meet increasing global demand in infant formula and infant nutrition.
Junction City, Kansas – Ventria Bioscience announced it has successfully increased production of lactoferrin. Lactoferrin is a protein that is found naturally in breastmilk and has been credited with improved health benefits for breastfed children. It is used worldwide in infant formula and other functional foods. Ventria produces its lactoferrin by extracting the protein from rice produced by Kansas farmers.
“Expansion of our lactoferrin production allows us to meet the increasing demand for this important nutrient which is used globally in infant formula and other infant nutrition products,” said Greg Unruh, General Manager. “We now have production to deliver thousands of kilograms of lactoferrin.”
About Ventria Bioscience
Ventria Bioscience develops and markets health and nutrition products using its protein production system called ExpressTec. This technology has made it possible to cost-effectively deliver protein-based functional ingredients to the global community. Its first two products are proteins that are found naturally in breastmilk and have been shown to have benefits for use in infant formula and other infant nutrition products.
###
Ventria Bioscience received the Friends of Education Award from the Geary County School District Board. Ventria received the award for their commitment to providing unique educational opportunities in biotechnology for students and teachers. Ventria has provided students with opportunities for job shadowing and internships in biotechnology. In 2007, Ventria provided a grant for a teacher from Junction City High School to attend the Biotechnology Institute’s Teacher-Leader program and provided a guided tour of their bioprocessing facility for the Junction City High School Science Department Faculty.
“As a new business in Junction City, Ventria Bioscience quickly demonstrated itself to be a corporate citizen committed to supporting public education. The company has become a tremendous asset for USD 475 and Junction City High School. The Geary County Schools and the Junction City Education Association are most pleased to recognize and honor Ventria with a Friends of Education Certificate of Award from the Confidence in Kansas Public Education Task Force,” said Charles Volland, District Communications Coordinator.
“Education is the foundation of future progress for society. Ventria is pleased to be able to contribute to educational opportunities for students and teachers in Junction City by supporting teacher training programs and offering student job shadowing and internships. We hope to inspire local students to see what is possible and become the next generation of scientists leading to a better tomorrow,” said Greg Unruh, Vice President and General Manager, Ventria Bioscience.
###